-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Why Aphria Stock Will Be the Next Billion-Dollar Pot Behemoth
APHA has big plans and the numbers to back them up, which will help make Aphria stock the next big thing in pot stocks.
3 Hot Investing Trends: Next Steps and Big Opportunities
The profit potential for investors who get in early on the marijuana, transportation and 5G trends is massive. Here's a quick update on each theme.
Here’s Why Tilray Stock Is a High-Risk, High-Reward Situation
TLRY stock has been, still is, and will remain the most volatile pot stock in the market.
A New Way to Make Money in Marijuana Stocks
Analysts who focus on only one way of investing in marijuana stocks are missing the forest for the trees.
A Historic Day in Congress Puts This HUGE Money-Making Theme One Step Closer
It’s only a matter of time before marijuana legalization hits more states -- and with federal government out of the way, the entire U.S.
Marijuana Legalization Inches Closer With Historic Reform Hearing
Marijuana legalization 2019 efforts are moving ahead following a reform hearing on Wednesday concerning the drug and we have the highlights.
Global Legalization Will Determine the Fate of Aurora Stock
Aurora's broad reach will make it a leader if global legalization accelerates -- and a loser if it doesn't.
Tilray Prepares a Second Act That Could Rekindle TLRY Stock
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
3 Reasons Cronos Group Stock Deserves A Buy Rating
Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.
Healthcare and Insurance Trends: 2 Hot Stocks to Buy
Investing in specific trends in the healthcare and insurance industries is a great financial decision today. And these are the hot stocks to buy now.
Can Vaping Growth Help Investors Extract More Value From Aphria Stock?
Aphria's interim CEO recognizes that vape products are growing while dried flower is slowing. That trend is one of the multiple catalysts likely to fuel APHA stock in the next year.
Aurora Cannabis Stock: Strong Potential, But This Isn’t the Time to Buy
Aurora Cannabis is making smarts moves globally, but the risks of oversupply and lack of strong American catalyst signal caution for investors.
Expect More Dips, Less Rips in Canopy Growth Stock
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
KERN Stock: What Happened, and What’s Next
Akerna (KERN) caused quite a bit of excitement in the pot stock community last week. Its meteoric rise might have looked magical – or like a fluke. But, in fact, KERN stock’s success has been a long time coming.
